Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
The Lipid-Oxidative Stress Axis: Novel Therapeutic Targets for Podocytopathy
by
Wang, Yuhong
, Liu, Yingxi
, Zou, Manshu
in
Antilipemic agents
/ chronic kidney disease
/ Chronic kidney failure
/ Development and progression
/ glomerular filtration barrier
/ Health aspects
/ lipid metabolism
/ lipotoxicity
/ Oxidative stress
/ Physiological aspects
/ podocyte
/ Review
/ Type 2 diabetes
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Lipid-Oxidative Stress Axis: Novel Therapeutic Targets for Podocytopathy
by
Wang, Yuhong
, Liu, Yingxi
, Zou, Manshu
in
Antilipemic agents
/ chronic kidney disease
/ Chronic kidney failure
/ Development and progression
/ glomerular filtration barrier
/ Health aspects
/ lipid metabolism
/ lipotoxicity
/ Oxidative stress
/ Physiological aspects
/ podocyte
/ Review
/ Type 2 diabetes
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
The Lipid-Oxidative Stress Axis: Novel Therapeutic Targets for Podocytopathy
by
Wang, Yuhong
, Liu, Yingxi
, Zou, Manshu
in
Antilipemic agents
/ chronic kidney disease
/ Chronic kidney failure
/ Development and progression
/ glomerular filtration barrier
/ Health aspects
/ lipid metabolism
/ lipotoxicity
/ Oxidative stress
/ Physiological aspects
/ podocyte
/ Review
/ Type 2 diabetes
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
The Lipid-Oxidative Stress Axis: Novel Therapeutic Targets for Podocytopathy
Journal Article
The Lipid-Oxidative Stress Axis: Novel Therapeutic Targets for Podocytopathy
2025
Request Book From Autostore
and Choose the Collection Method
Overview
Podocytes, as terminally differentiated cells within the glomerulus, play a decisive role in maintaining the molecular selectivity of the glomerular filtration barrier (GFB) through structural integrity and functional homeostasis. Podocyte injury not only directly compromises GFB integrity but also serves as a central pathological mechanism underlying the progression of proteinuric nephropathy. Evidence from studies highlights an intricate link between lipid metabolism dysregulation and podocyte dysfunction: Renal ectopic lipid accumulation (ELA) disrupts intracellular homeostasis via lipotoxic effects, inducing mitochondrial oxidative stress, cytoskeletal remodeling, and inflammatory cascades. Concurrently, excessive reactive oxygen species (ROS) generation coupled with compromised antioxidant defense mechanisms establishes a self-perpetuating cycle of redox imbalance. This bidirectional crosstalk within the lipid-oxidative stress axis triggers irreversible pathological alterations. This review summarizes the effects of abnormal signals during lipid synthesis, breakdown, and metabolism on podocytes, as well as the interaction between mitochondria and podocyte dysfunction through signaling mechanisms in lipid metabolism disorders. We also sorted out the key molecular pathways involved in this axis, and the regulation of key nodes of lipid metabolism (SREBP pathway, HMGCR pathway), improvement of mitochondrial function (mitochondrial dynamics and energy metabolism), and activation of antioxidant defenses (AMPK pathway) are highly promising therapeutic targets for intervening in podocyte damage and blocking the progression of the disease.
Publisher
Dove Medical Press Limited,Dove Press,Dove Medical Press
This website uses cookies to ensure you get the best experience on our website.